Truist Financial Corp lessened its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 17.4% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 63,413 shares of the medical device company’s stock after selling 13,334 shares during the period. Truist Financial Corp’s holdings in Cooper Companies were worth $5,197,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. JANA Partners Management LP bought a new position in Cooper Companies during the third quarter worth $166,917,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies during the third quarter worth $11,341,000. Massachusetts Financial Services Co. MA raised its stake in Cooper Companies by 96.9% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after buying an additional 1,525,693 shares during the last quarter. Alecta Tjanstepension Omsesidigt increased its stake in Cooper Companies by 15.8% in the third quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after purchasing an additional 213,500 shares in the last quarter. Finally, DAVENPORT & Co LLC increased its stake in Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock valued at $46,642,000 after purchasing an additional 528,346 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on COO shares. William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Weiss Ratings upgraded shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Needham & Company LLC lifted their price objective on shares of Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a report on Friday, March 6th. Finally, Barclays lifted their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average target price of $90.79.
Cooper Companies Price Performance
Cooper Companies stock opened at $60.00 on Monday. The Cooper Companies, Inc. has a fifty-two week low of $59.68 and a fifty-two week high of $89.83. The stock has a market cap of $11.71 billion, a PE ratio of 29.70, a price-to-earnings-growth ratio of 1.55 and a beta of 0.89. The firm’s 50-day simple moving average is $71.18 and its 200 day simple moving average is $76.08. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.03 by $0.07. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the company earned $0.92 earnings per share. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Research analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.
Cooper Companies Profile
Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.
The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.
Featured Stories
- Five stocks we like better than Cooper Companies
- 3 Companies Quietly Essential to Data Center and AI Operations
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
